Physician profile
William A Dabbs
NPI 1326049040
$881.30
in general payments reported to CMS, 2019-2025
17 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $23.34 · 2022: $49.70 · 2023: $241 · 2024: $41.38 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $213.58 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Sobi, INC | $120.24 | 2025 | |
| Boston Scientific Corporation | $119.41 | 2019 | |
| Glaxosmithkline, LLC. | $65.85 | 2019-2023 | Shingrix, Arexvy |
| Nevro Corp. | $56.82 | 2022-2023 | Senza |
| Pfizer INC. | $55.59 | 2019-2025 | |
| Abbvie INC. | $40.67 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.30 | 2022 | |
| Lilly USA, LLC | $28.03 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.62 | 2019 | |
| Amarin Pharma, INC. | $23.34 | 2020 | |
| Gilead Sciences, INC. | $22.88 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $19.79 | 2019 | |
| Bausch Health US, LLC | $16.42 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.21 | 2025 | Trintellix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.00 | 2019 | |
| Shire North American Group INC | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dabbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.